Rocket Pharmaceuticals Inc
Research Rocket Pharmaceuticals Inc (RCKT) on Bullrun: market cap USD 412.75M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRCKT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 412.75M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 47.59M
- Free cash flow-USD 179.79M
Valuation Snapshot
latest market cap is USD 412.75M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 223.12M | -USD 190.45M | n/a | -2.01 | USD 77.56M | USD 24.88M | USD 277.22M |
| FY2024 | USD 0 | -USD 258.75M | -USD 215.59M | n/a | -2.73 | USD 163.64M | USD 25.50M | USD 463.23M |
| FY2023 | USD 0 | -USD 245.60M | -USD 211.35M | n/a | -2.92 | USD 55.90M | USD 25.04M | USD 492.57M |
| FY2022 | USD 0 | -USD 221.86M | -USD 186.50M | n/a | -3.26 | USD 140.52M | USD 22.27M | USD 489.69M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 412.75M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 380.20M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.34B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.70B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.54B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.41B | n/a | n/a | n/a |
About Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Rocket Pharmaceuticals Inc's market cap?
Rocket Pharmaceuticals Inc's market capitalization is USD 412.75M.
What does Rocket Pharmaceuticals Inc do?
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States.